| Oligomerization of mannan‐binding lectin dictates binding properties and complement activation TR Kjaer, L Jensen, A Hansen, R Dani, JC Jensenius, J Dobó, P Gál, ... Scandinavian Journal of Immunology 84 (1), 12-19, 2016 | 32 | 2016 |
| Cutting edge: a new player in the alternative complement pathway, MASP-1 is essential for LPS-induced, but not for zymosan-induced, alternative pathway activation K Paréj, A Kocsis, C Enyingi, R Dani, G Oroszlán, L Beinrohr, J Dobó, ... The Journal of Immunology 200 (7), 2247-2252, 2018 | 26 | 2018 |
| Extensive basal level activation of complement mannose-binding lectin-associated serine protease-3: kinetic modeling of lectin pathway activation provides possible mechanism G Oroszlán, R Dani, A Szilágyi, P Závodszky, S Thiel, P Gál, J Dobó Frontiers in immunology 8, 308660, 2017 | 23 | 2017 |
| Proprotein convertase is the highest-level activator of the alternative complement pathway in the blood G Oroszlán, R Dani, BM Végh, D Varga, AV Ács, G Pál, P Závodszky, ... The Journal of Immunology 206 (9), 2198-2205, 2021 | 15 | 2021 |
| Proprotein convertases and the complement system J Dobó, A Kocsis, R Dani, P Gál Frontiers in Immunology 13, 958121, 2022 | 9 | 2022 |
| Quantification of the zymogenicity and the substrate-induced activity enhancement of complement factor D R Dani, G Oroszlán, R Martinusz, B Farkas, B Dobos, E Vadas, ... Frontiers in Immunology 14, 1197023, 2023 | 3 | 2023 |
| Abstracts from the 10th C1-inhibitor deficiency workshop AH Schmaier, M Cicardi, A Reshef, D Moldovan, A Mócsai, ... Allergy, Asthma & Clinical Immunology 13, 1-36, 2017 | 2 | 2017 |
| C3b-complexed factor B is a several million-fold better substrate for factor D than factor B alone. A comparative kinetic study R Dani, G Oroszlán, B Dobos, E Vadas, P Závodszky, P Gál, J Dobó Molecular Immunology 102, 144, 2018 | 1 | 2018 |
| Activation of MASP-3 by PCSK6 links the complement and the proprotein convertase systems in the blood G Oroszlan, R Dani, BM Vegh, D Varga, AV Acs, G Pal, P Zavodszky, ... MOLECULAR IMMUNOLOGY 141, 124-124, 2022 | | 2022 |
| THE ACTIVATOR OF MASP-3 IN THE BLOOD IS PROBABLY NOT A COMPONENT OF THE COMPLEMENT LECTIN PATHWAY G Oroszlan, R Dani, G Pal, P Zavodszky, H Farkas, P Gal, J Dobo MOLECULAR IMMUNOLOGY 114, 461-462, 2019 | | 2019 |
| THE ROLE OF MASP-1 IN THE ALTERNATIVE PATHWAY ACTIVATION A Kocsis, B Kovacs, B Vegh, R Dani, N Sandor, G Oroszlan, J Dobo, ... MOLECULAR IMMUNOLOGY 114, 459-460, 2019 | | 2019 |
| MASP-1 is a major contributor to the defense against Gram-negative bacteria A Kocsis, B Végh, R Dani, G Oroszlán, J Dobó, P Závodszky, G Pál, P Gál Molecular Immunology 102, 159, 2018 | | 2018 |
| Activation of the complement system is hampered in type 2 diabetes mellitus, during bacterial infection compared with controls D Csuka, L Barkai, K Pilely, R Dani, J Dobó, E Sipter, Z Prohászka, P Gál, ... Molecular Immunology 102, 141-142, 2018 | | 2018 |
| Gábor Oroszlán1, Ráhel Dani1, András Szilágyi1, Péter Závodszky1, Steffen Thiel2, Péter Gál1 and József Dobó1 Z Fishelson, T Fujita, L Isaac, J Dobó, G Oroszlán, R Dani, A Szilágyi, ... Frontiers in Immunology 8 (1821), 1, 2017 | | 2017 |
| The activated form of complement MASP-3 is the major variant in resting blood J Dobó, G Oroszlán, R Dani, A Szilágyi, P Závodszky, S Thiel, P Gál Molecular Immunology 89, 194-195, 2017 | | 2017 |
